Ketofast Ketofast


FDA Smacks Pravachol for Misleading Ads

Direct-to-consumer drug advertising has tripled to $2.8 billion worth a year since the FDA loosened restrictions in 1997. Manufacturers spend almost twice that amount on sales visits to doctors to promote their products, and another $2 billion on "educational" events.

If this story interests you, please review the Lancet article I posted earlier this year on how drug ads in medical journals are also highly deceptive.

Associated Press August 9, 2003

Click Here and be the first to comment on this article
Post your comment